Feline Arrhythmogenic Right Ventricular Cardiomyopathy

Feline Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is a rare but serious primary myocardial disease characterized by progressive replacement of right ventricular (and sometimes left ventricular) myocardium with fibrous and/or adipose tissue, leading to structural dysfunction, life-threatening arrhythmias, and heart failure [1][2]. Although ARVC is well-recognized as an important cause of sudden cardiac death in humans and in Boxers among dogs, it is infrequently reported in domestic cats [1][2]. The disease can affect adult cats of either sex and any breed, and is considered part of the broader group of non-hypertrophic cardiomyopathies recognized in feline medicine [1]. Its rarity, combined with its potentially catastrophic clinical course, makes early recognition and diagnosis especially important for affected patients.

The precise etiology of feline ARVC is not fully established, but the core pathological process involves progressive fibro-fatty infiltration and replacement of the right ventricular myocardium, a process that disrupts the structural integrity and electrical homogeneity of the myocardial wall [1][2]. This replacement begins in the epicardium and progresses toward the endocardium, creating regions of electrical instability that serve as substrates for re-entrant arrhythmias, including ventricular premature complexes (VPCs) with left bundle branch block morphology, ventricular tachycardia, and potentially fatal arrhythmias [2][3].

In some feline cases, the disease extends significantly into the left ventricle, suggesting a biventricular form of ARVC that carries particularly severe clinical consequences [3]. Histopathological examination of affected hearts confirms myocardial atrophy alongside infiltration by adipose and fibrous connective tissue, consistent with descriptions in humans and Boxers [2][3].

The genetic basis of feline ARVC has not been definitively characterized. In human medicine, ARVC is commonly linked to mutations in desmosomal proteins (such as plakophilin-2, desmoplakin, and desmoglein-2), which are responsible for maintaining cell-to-cell adhesion in cardiomyocytes under mechanical stress [4]. By analogy, genetic and molecular mechanisms involving structural proteins of the intercalated disc are suspected in veterinary species, though specific mutations causative of feline ARVC have yet to be identified [4]. The growing field of personalized medicine and genetic testing in companion animal cardiology may eventually illuminate the hereditary contributions to this disease [4].

Structural changes in the right ventricular free wall — including marked thinning and aneurysmal dilation — reduce wall motion, impair filling and ejection, and ultimately lead to right heart failure with secondary pleural and abdominal effusions [2][3]. The arrhythmogenic substrate created by fibro-fatty replacement explains the high risk of life-threatening rhythm disturbances and sudden death observed in affected cats [2].

Electrocardiography (ECG) and Holter Monitoring Standard 12-lead or 6-lead ECG may reveal ventricular premature complexes, ventricular tachycardia, or complete atrioventricular block [2][5]. Twenty-four-hour ambulatory (Holter) monitoring is particularly valuable for quantifying arrhythmia burden and characterizing morphology; in confirmed ARVC cases, numerous polymorphic VPCs with both left and right bundle branch block morphologies have been documented, reflecting multifocal arrhythmogenic foci arising from both ventricles [3][5]. Holter recording may reveal findings such as complete AV block or frequent VPCs that are not detected on brief in-clinic ECG recordings [2][5].

Echocardiography Echocardiographic examination is a cornerstone of diagnosis. Key findings include right atrial and right ventricular dilation, thinning of the right ventricular free wall, and, in severe cases, aneurysmal bulging of the right ventricular wall [2][3]. Reduced right ventricular systolic function is typically observed. In some cats, concurrent left ventricular dilation or dysfunction may also be detected, indicating biventricular involvement [3].

Thoracic Radiography Chest radiographs commonly demonstrate pleural effusion, right-sided cardiomegaly, and, in some cases, evidence of hepatomegaly or ascites consistent with right-sided congestive heart failure [1][2].

Laboratory Diagnostics Although no laboratory finding is pathognomonic for ARVC, routine bloodwork supports case management and helps rule out other conditions:

• ·Complete Blood Count (CBC): HCT may be mildly reduced or normal; no specific changes are characteristic of ARVC itself, though chronic illness may cause mild anemia.
• ·Serum Biochemistry: BUN and CREA may be elevated if cardiac output is severely reduced, causing pre-renal azotemia. ALT may be mildly elevated in hepatic congestion secondary to right-sided heart failure. Electrolyte disturbances (hypokalemia, hyponatremia) may develop secondary to diuretic therapy.
• ·Albumin (ALB) and total protein: Hypoalbuminemia may develop with chronic effusive disease or reduced hepatic synthetic function from congestion.
• ·Cardiac Biomarkers: Serum cardiac troponin I (cTnI) and NT-proBNP may be elevated in cats with myocardial injury and heart failure; these markers support the presence of significant myocardial disease, though they are not specific to ARVC.

Necropsy and Histopathology Definitive diagnosis often relies on post-mortem gross and histopathological examination. Characteristic findings include macroscopic right ventricular dilation and wall thinning, with microscopic confirmation of fibro-fatty replacement of cardiomyocytes [2][3]. In one reported case, gross and histopathological findings included severe left ventricular involvement alongside classic right ventricular changes [3].

Differential Diagnoses ARVC must be distinguished from other feline cardiomyopathies (HCM, DCM, RCM, NCM), pericardial disease, and secondary causes of right heart failure, such as pulmonary hypertension or heartworm disease [1].

There is no curative treatment for feline ARVC; management is aimed at controlling arrhythmias, managing heart failure, and improving quality of life [1][2].

Antiarrhythmic Therapy Control of ventricular arrhythmias is a primary therapeutic goal. Medications used include:

• ·Sotalol: A class III antiarrhythmic agent with beta-blocking properties, often considered for management of ventricular tachyarrhythmias in cats with ARVC [2].
• ·Atenolol: A beta-1 selective blocker that may help reduce arrhythmia frequency and heart rate [1][2].
• ·Mexiletine: A class IB antiarrhythmic agent sometimes combined with sotalol for refractory ventricular arrhythmias, though published feline-specific data remain limited.

Heart Failure Management In cats presenting with right-sided congestive heart failure (pleural effusion, ascites):

• ·Thoracocentesis: Immediate relief of respiratory distress by drainage of pleural effusion is often required as an emergency measure [2][3].
• ·Furosemide (a loop diuretic): Administered to reduce fluid accumulation and venous congestion. Electrolytes (especially potassium) should be monitored closely during diuretic use, as hypokalemia can exacerbate arrhythmias.
• ·Aldosterone antagonists (e.g., spironolactone): May be added for additional fluid management and potential cardioprotective effects.
• ·ACE inhibitors (e.g., enalapril, benazepril): May be used adjunctively, though their efficacy specifically in right-sided failure in cats with ARVC is not well-documented.

Pacemaker Implantation In cases where complete AV block is documented and contributes to hemodynamic compromise or syncope, cardiac pacing has been reported as a therapeutic consideration in small animals, though this remains technically challenging and is not widely available in all practices [2].

Supportive and Nutritional Care

• ·Dietary sodium restriction and stress minimization are generally recommended for cats in heart failure.
• ·Omega-3 fatty acid supplementation has been proposed as a potentially antiarrhythmic adjunct in some cardiomyopathy cases, though evidence in feline ARVC specifically is lacking.
• ·Taurine supplementation is not expected to be beneficial in ARVC (unlike some forms of DCM), as taurine deficiency is not part of the known pathophysiology.

The prognosis for cats diagnosed with ARVC is generally considered poor to grave, particularly in those presenting with advanced right-sided heart failure or life-threatening arrhythmias [1][2]. Feline ARVC carries a high risk of sudden cardiac death, which may occur even before heart failure signs develop [1][2].

In the small case series and case reports available in the veterinary literature, outcomes have been consistently poor. In one reported case, a cat with confirmed ARVC and severe biventricular involvement died only 10 days after initiation of antiarrhythmic therapy, despite attempted treatment [3]. In other reported cases, survival times were similarly short after clinical presentation, with death resulting from refractory arrhythmias or progressive heart failure [2].

Specific population-level survival statistics for feline ARVC are not available due to the rarity of the disease and the very small number of published cases [1][2][3]. However, in aggregate, the cases documented in peer-reviewed literature suggest a median survival measured in days to weeks following diagnosis in cats presenting with overt clinical signs. Sudden death as the first and only manifestation of disease has also been reported, emphasizing the life-threatening nature of this condition even in apparently subclinical cats [1][2].

Factors associated with a worse prognosis include:

• ·Severe right ventricular free wall thinning or aneurysm formation
• ·Biventricular involvement [3]
• ·Complete AV block or sustained ventricular tachycardia [2]
• ·Refractory pleural effusion
• ·Evidence of multiorgan compromise (azotemia, hepatic congestion)

Currently, no specific preventive strategies are established for feline ARVC, primarily because the genetic and molecular etiology of the disease in cats has not been definitively characterized [1][4].

Genetic Testing In human medicine and in Boxer dogs with ARVC, genetic screening for desmosomal gene mutations has been used to identify at-risk individuals before clinical disease develops [4]. Analogous screening programs do not yet exist for cats, as the causative genetic variants in the feline form of the disease remain unidentified [4]. Advances in personalized veterinary medicine and whole-genome sequencing may eventually enable pre-symptomatic identification of susceptible cats [4].

Breeding Considerations Given the suspected heritable nature of many primary cardiomyopathies in cats, affected cats and their close relatives should ideally not be used for breeding. However, without validated genetic tests or known high-risk breeds for feline ARVC specifically, formal breeding exclusion programs are not currently possible [1][4].

General Cardiac Surveillance

• ·Annual or biannual echocardiographic screening in adult cats, particularly those from lines with known cardiac disease, may allow earlier detection of structural abnormalities before severe symptoms or sudden death occur [1].
• ·Routine physical examination with attention to cardiac auscultation (detection of arrhythmias or murmurs) and thoracic auscultation may prompt earlier diagnostic workup.

Owner Education Owners of cats with known cardiomyopathy diagnoses should be educated about the risk of sudden cardiac death and the signs of acute decompensated heart failure (rapid or labored breathing, open-mouth breathing, collapse), enabling prompt emergency veterinary care.